Synthesis and membrane behavior of a new class of unnatural phospholipid analogs useful as phospholipase A2 degradable liposomal drug carriers

被引:13
作者
Andresen, TL
Jorgensen, K
机构
[1] Tech Univ Denmark, LiPlasome Pharma AS, DK-2800 Lyngby, Denmark
[2] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2005年 / 1669卷 / 01期
关键词
liposomes; lipid synthesis; ripple phase formation; phospholipase A2; enzyme lipid interaction; liposomal drug carrier; lipid membrane heterogeneity; calorimetry; fluorescence;
D O I
10.1016/j.bbamem.2005.02.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new and unnatural type of lipid analogs with the phosphocholine and phosphoglycerol head groups linked to the C-2 position of the glycerol moiety have been synthesized and the thermodynamic lipid membrane behavior has been investigated using differential scanning calorimetry. From the heat capacity measurements, it was observed that the pre-transition was abolished most likely due to the central position of the head groups providing better packing properties in the low temperature ordered gel phase. Activity measurements of secretory phospholipase A2 (PLA2) on unilamellar liposomal membranes revealed that the unnatural phospholipids are excellent substrates for PLA2 catalyzed hydrolysis. This was manifested as a minimum in the PLA2 lag time in the main phase transition temperature regime and a high degree of lipid hydrolysis over a broad temperature range. The obtained results provide new information about the interplay between the molecular structure of phospholipids and the lipid membrane packing constrains that govern the pre-transition. In addition, the PLA2 activity measurements are useful for obtaining deeper insight into the molecular details of the catalytic site of PLA2. The combined results also suggest new approaches to rationally design liposomal drug carries that can undergo a triggered activation in diseased tissue by overexpressed PLA2. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 43 条
[1]  
Abe T, 1997, INT J CANCER, V74, P245, DOI 10.1002/(SICI)1097-0215(19970620)74:3<245::AID-IJC2>3.0.CO
[2]  
2-Z
[3]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[4]   Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs [J].
Andresen, TL ;
Davidsen, J ;
Begtrup, M ;
Mouritsen, OG ;
Jorgensen, K .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1694-1703
[5]   Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release [J].
Andresen, TL ;
Jensen, SS ;
Jorgensen, K .
PROGRESS IN LIPID RESEARCH, 2005, 44 (01) :68-97
[6]   Liposome application: problems and prospects [J].
Barenholz, Y .
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2001, 6 (01) :66-77
[7]   The 2003 ASBMB-Avanti Award in Lipids address: applications of novel synthetic lipids to biological problems [J].
Bittman, R .
CHEMISTRY AND PHYSICS OF LIPIDS, 2004, 129 (02) :111-131
[8]   Structure of detergent-resistant membrane domains: Does phase separation occur in biological membranes? [J].
Brown, DA ;
London, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (01) :1-7
[9]   Molecular recognition of tyrosinyl adenylate analogues by prokaryotic tyrosyl tRNA synthetases [J].
Brown, P ;
Richardson, CM ;
Mensah, LM ;
O'Hanlon, PJ ;
Osborne, NF ;
Pope, AJ ;
Walker, G .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) :2473-2485
[10]   ROLE OF LATERAL PHASE-SEPARATION IN THE MODULATION OF PHOSPHOLIPASE-A2 ACTIVITY [J].
BURACK, WR ;
YUAN, Q ;
BILTONEN, RL .
BIOCHEMISTRY, 1993, 32 (02) :583-589